Announcement of the financial report for the year of 2021
· Issued by Tty Biopharm Company Limited
Close
Today's Information
Provided by: TTY BIOPHARM COMPANY LIMITED
SEQ_NO
3
Date of announcement
2022/03/09
Time of announcement
21:09:12
Subject
Announcement of the financial report
for the year of 2021
Date of events
2022/03/09
To which item it meets
paragraph 31
Statement
1.Date of the board of directors submitted or approved:2022/03/09
2.Date of the audit committee approved:2022/03/09
3.Start and end dates of financial reports or unaudited financial
information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):
2021/01/01~2021/12/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):4,535,610
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):2,766,553
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):1,140,652
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):1,087,380
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):822,569
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):831,894
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):3.35
11.Total assets end of the period (thousand NTD):9,296,465
12.Total liabilities end of the period
(thousand NTD):3,529,231
13.Equity attributable to owners of parent end of the
period (thousand NTD):5,167,855
14.Any other matters that need to be specified:None.
